IDH1 and central nervous system cancer: Recently, some research groups found a unique biomarker——2HG in glioma5–8, which is over-accumulated during the process of lesion: Mutations in isocitrate dehydrogenase 1 and 2 (IDH1, IDH2) are widespread in IDH-mutated glioma patients.